3,951 to 3,960 of 8,693 Results
Comma Separated Values - 53.2 KB -
MD5: 30c1d9372e847d33499be7b7a3607de4
|
Comma Separated Values - 4.1 KB -
MD5: 3fb1dbc65fe7fc08e04d3b22413dd6fc
|
Comma Separated Values - 53.2 KB -
MD5: fa9db09a6c7bb4913ff724f58fc89804
|
Comma Separated Values - 1.8 KB -
MD5: 2d9e24232a8e9ca81d055baeb21ad4c7
|
Comma Separated Values - 53.2 KB -
MD5: df2fc111ae0fafa06bd973e74222b68a
|
Comma Separated Values - 6.1 KB -
MD5: 4708c9eef03c4b1d5b507863b629382b
|
Comma Separated Values - 53.2 KB -
MD5: 1121638b88369aa95c3a25a3c041b2b4
|
Comma Separated Values - 5.8 KB -
MD5: a6b5762cb8ce7157bf7c95fbc3f44ed4
|
Comma Separated Values - 53.2 KB -
MD5: a01784f03b6d48cb6e90fbc981e8f4b9
|
Sep 6, 2022 - DiTECT-HAT
Lejon, Veerle; Ngay Lukusa, Ipos; Mumba Ngoyi, Dieudonné; Van Reet, Nick; Buscher, Philippe, 2022, "Diagnostic Tools for Human African Trypanosomiasis Elimination and Clinical Trials: WP4 Early test-of-cure", https://doi.org/10.23708/MBMROD, DataSuds, V2
In the last decade, the prevalence of Trypanosoma brucei gambiense human African trypanosomiasis (HAT) has fallen and HAT has been targeted for elimination. Clinical trials on safe and efficacious drugs for HAT, applicable in an elimination context, would be accelerated by availa... |
